Omar Abboud1. 1. Department of Medicine, Hamad Medical Corporation, Doha, Qatar. oiabboud@yahoo.com
Abstract
INTRODUCTION: This article reviews the status of end-stage renal disease in the Middle East, with emphasis on its incidence, prevalence, and treatment. METHODS: Data were obtained from English-language published literature through a Medline search over the past 40 years. Supplementary information was gathered from regional congresses and symposia, websites of specialized nephrology centers, and direct communications. RESULTS: Of the 14 Middle East countries, attention was focused on 10 countries with similar renal care systems: 7 Arabian Peninsula countries and 3 eastern Mediterranean countries. Collectively, they have a population of 72.5 million. Incidence of ESRD ranged between 64 and 212 patients per million population (pmp) with an average of 93 patients pmp. The lowest prevalence was 320, the highest was 462, and the average was 352 patients pmp. Hemodialysis is the preferred dialysis modality and is freely available in all countries for citizens. Non-citizen residents' access to hemodialysis is markedly restricted. Peritoneal dialysis is available on a limited scale. Renal transplantation is available in all countries with variable program activities. Most of the transplants are from living, related donors. Active deceased donor transplant programs exist in four countries. The results from countries with active programs are excellent, with 5-year patient and graft survival of > 90%. CONCLUSIONS: This review provides information on the incidence, prevalence and treatment modalities of ESRD in 10 Middle East countries.
INTRODUCTION: This article reviews the status of end-stage renal disease in the Middle East, with emphasis on its incidence, prevalence, and treatment. METHODS: Data were obtained from English-language published literature through a Medline search over the past 40 years. Supplementary information was gathered from regional congresses and symposia, websites of specialized nephrology centers, and direct communications. RESULTS: Of the 14 Middle East countries, attention was focused on 10 countries with similar renal care systems: 7 Arabian Peninsula countries and 3 eastern Mediterranean countries. Collectively, they have a population of 72.5 million. Incidence of ESRD ranged between 64 and 212 patients per million population (pmp) with an average of 93 patients pmp. The lowest prevalence was 320, the highest was 462, and the average was 352 patients pmp. Hemodialysis is the preferred dialysis modality and is freely available in all countries for citizens. Non-citizen residents' access to hemodialysis is markedly restricted. Peritoneal dialysis is available on a limited scale. Renal transplantation is available in all countries with variable program activities. Most of the transplants are from living, related donors. Active deceased donor transplant programs exist in four countries. The results from countries with active programs are excellent, with 5-year patient and graft survival of > 90%. CONCLUSIONS: This review provides information on the incidence, prevalence and treatment modalities of ESRD in 10 Middle East countries.
Authors: Faten Al Zaben; Doaa Ahmed Khalifa; Mohammad Gamal Sehlo; Saad Al Shohaib; Salma Awad Binzaqr; Alae Magdi Badreg; Rawan Ali Alsaadi; Harold G Koenig Journal: J Relig Health Date: 2015-04
Authors: Faten Al Zaben; Mohammad Gamal Sehlo; Doaa Ahmed Khalifa; Saad Al Shohaib; Faisul Shaheen; Linda Alzaben; Rami Ghazi Ahmad; Jafar Ayman Ashy; Reema Ghazi Felemban; Harold G Koenig Journal: Int Urol Nephrol Date: 2015-04-22 Impact factor: 2.370
Authors: Faten Al Zaben; Doaa Ahmed Khalifa; Mohammad Gamal Sehlo; Saad Al Shohaib; Faisul Shaheen; Hanadi Alhozali; Alferdose Osama Hariri; Riyadh Ghazi Ahmad; Moayad Reda Kabli; Harold G Koenig Journal: Int Urol Nephrol Date: 2014-08-28 Impact factor: 2.370
Authors: J Hassanzadeh; A A Hashiani; A Rajaeefard; H Salahi; E Khedmati; F Kakaei; S Nikeghbalian; A Malek-Hossein Journal: Indian J Nephrol Date: 2010-10
Authors: A Almasi-Hashiani; A R Rajaeefard; J Hassanzade; H Salahi; S Nikeghbalian; P Janghorban; S A Malek-Hosseini Journal: Iran Red Crescent Med J Date: 2011-06-01 Impact factor: 0.611
Authors: Sarah L White; Richard Hirth; Beatriz Mahíllo; Beatriz Domínguez-Gil; Francis L Delmonico; Luc Noel; Jeremy Chapman; Rafael Matesanz; Mar Carmona; Marina Alvarez; Jose R Núñez; Alan Leichtman Journal: Bull World Health Organ Date: 2014-08-22 Impact factor: 9.408